Pages that link to "Q62774647"

The following pages link to Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer (Q62774647):

Displaying 22 items.

• Potential role for metformin in urologic oncology (Q26747759) (← links)
• Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis (Q28074225) (← links)
• Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies (Q28081491) (← links)
• MATE2 Expression Is Associated with Cancer Cell Response to Metformin (Q28555000) (← links)
• Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways (Q36005565) (← links)
• Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies (Q36370966) (← links)
• Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients (Q36410079) (← links)
• High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with ∼240-Fold Higher Drug Concentration in Urine than Serum (Q36665063) (← links)
• Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus (Q37153221) (← links)
• New insight for metformin against bladder cancer (Q37733377) (← links)
• The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo (Q39042097) (← links)
• Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer (Q40903985) (← links)
• The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder (Q41652070) (← links)
• The landscape of genetics and biomarkers in bladder cancer (Q49479865) (← links)
• Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy (Q50943065) (← links)
• Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis. (Q55239950) (← links)
• Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: a systematic review and meta-analysis (Q58694444) (← links)
• The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer (Q61454755) (← links)
• Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis (Q90470049) (← links)
• No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression (Q90635025) (← links)
• Prostate Cancer Energetics and Biosynthesis (Q92410918) (← links)
• Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults (Q94683791) (← links)